Carla P. Amaro
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A retrospective database analysis to understand treatment patterns and outcomes of intermediate and advanced hepatocellular carcinoma in Alberta, Canada (A-CAPTAIN study).
Journal: Journal of gastrointestinal oncology
Published: September 17, 2024
Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018-2021) compared to the sorafenib era (2008-2018).
Journal: Cancer medicine
Published: January 30, 2024
Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study.
Journal: International journal of radiation oncology, biology, physics
Published: April 20, 2022
Metastatic pancreatic cancer with complete response to FOLFIRINOX treatment.
Journal: BMJ case reports
Published: May 25, 2021
First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta.
Journal: Current oncology (Toronto, Ont.)
Published: March 31, 2021
Management of hepatocellular carcinoma after progression on first-line systemic treatment: defining the optimal sequencing strategy in second line and beyond.
Journal: Current oncology (Toronto, Ont.)
Published: December 21, 2020
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.
Journal: Cancer medicine
Published: March 03, 2020
CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease.
Journal: Therapeutic advances in medical oncology
Published: August 01, 2018
Integrated solutions for urban runoff pollution control in Brazilian metropolitan regions.
Journal: Water science and technology : a journal of the International Association on Water Pollution Research
Published: July 07, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026